Trastuzumab

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17110 publications

Trastuzumab-deruxtecan (T-DXd) in HER2+ metastatic breast cancer: efficacy, clinical management, and perspectives.

Trastuzumab-deruxtecan (T-DXd) in HER2+ metastatic breast cancer: efficacy, clinical management, and perspectives.

Journal: Recenti progressi in medicina
Published: January 22, 2026

Antibodies to watch in 2026.

Antibodies to watch in 2026.

Journal: mAbs
Published: January 21, 2026

Impact of antiemetic prophylaxis on reducing trastuzumab deruxtecan dose modifications in HER2+/HER2-low breast cancer.

Impact of antiemetic prophylaxis on reducing trastuzumab deruxtecan dose modifications in HER2+/HER2-low breast cancer.

Journal: Future oncology (London, England)
Published: January 19, 2026

Real-World Outcomes With Inetetamab-Based Regimens for HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Analysis in China.

Real-World Outcomes With Inetetamab-Based Regimens for HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Analysis in China.

Journal: Cancer control : journal of the Moffitt Cancer Center
Published: January 19, 2026

A Case of Pancreatic Metastasis after Breast Cancer Surgery

A Case of Pancreatic Metastasis after Breast Cancer Surgery

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026

Pancreatoduodenectomy as Conversion Surgery for Advanced or Recurrent Gastric Cancer-A Report of Six Cases

Pancreatoduodenectomy as Conversion Surgery for Advanced or Recurrent Gastric Cancer-A Report of Six Cases

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026

Subtype Change and Treatment Refractoriness at the Time of Recurrence in a Patient with Breast Cancer

Subtype Change and Treatment Refractoriness at the Time of Recurrence in a Patient with Breast Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026

Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients.

Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients.

Journal: JAMA network open
Published: January 15, 2026

Guidelines for managing adverse reactions to antibody-drug conjugates in breast cancer (2025 edition)

Guidelines for managing adverse reactions to antibody-drug conjugates in breast cancer (2025 edition)

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: January 15, 2026

Air Pollution and Cardiac Remodeling and Function in Patients With Breast Cancer.

Air Pollution and Cardiac Remodeling and Function in Patients With Breast Cancer.

Journal: JAMA network open
Published: January 15, 2026

Aptamer-based conjugated molecules in experimental and clinical approaches to treatment of glioblastoma

Aptamer-based conjugated molecules in experimental and clinical approaches to treatment of glioblastoma

Journal: Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
Published: January 13, 2026

Baseline Tumor Biology Predicts Survival After Recurrence in Gastric Cancer: Impact of LVI, PNI, and HER2 Status.

Baseline Tumor Biology Predicts Survival After Recurrence in Gastric Cancer: Impact of LVI, PNI, and HER2 Status.

Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: January 09, 2026
Showing 1-12 of 17,110

Last Updated: 02/24/2026